[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.21(금)

Global Data Intelligence Center
구분	보고서 (영문)	업로드 날짜
제약/바이오/ 임상시험	Eli Lilly’s Donanemab Flaunts Strong Clinical Profile in Data Read-out, Ready to Compete with Leqembi	07-18-2023
	Success of FluMist Quadrivalent in UK Unlikely to Be Matched in Japan	07-17-2023
	CellTrans’s Lantidra Is the First in a Growing Line of Cell Therapies Expected to Personalize Treatment Paradigms in Type 1 Diabetes	07-12-2023
	BioCardia Submits Japan Application for Leading Product CardiAMP to Treat Ischemic HFrEF	07-11-2023
	Investor Sentiment Surges for US Companies, with European and APAC Firms Undervalued	07-06-2023
	Broader Coverage for Eisai/Biogen’s Leqembi Follows Traditional FDA Approval	07-07-2023
	BioMarin’s Roctavian Becomes the First FDA-Approved Gene Therapy for Severe Hemophilia A	07-07-2023
질환별	Risk of Chronic Conditions Associated with Heavy Alcohol Intake in Chinese Men	07-12-2023
	Novel Pipeline Therapies to Drive PD Market Across 7MM to $6.4 Billion in 2029	07-14-2023
	Domestic Cases of Malaria Confirmed in the US	07-13-2023
	Autism Spectrum Disorder Competitive Landscape	07-13-2023
	HTA Outcomes in the 5EU Are Growing at a Rate of 27% With a Deep Commitment to Oncology	07-12-2023
	Atrial Fibrillation Market Set to Decline at a CAGR of 1.3% Between 2022 and 2032	07-12-2023
	Parkinson’s Disease – Seven Market Drug Forecast and Market Analysis – Update	07-12-2023
	Alcohol Use Disorder: Competitive Landscape	07-10-2023
	Atrial Fibrillation: 68-Market Analysis and Sales Forecast	06-27-2023
	More Children Diagnosed with Type 1 Diabetes Post COVID-19 Pandemic	07-10-2023
컨퍼런스/심포지엄/학회	Highlights from the EHA Congress 2023 Meeting: Allogeneic Cell Therapy Updates	06-14-2023